Literature DB >> 25832152

The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes.

Stephen M Twigg1, Jencia Wong2.   

Abstract

Diabetes mellitus and its complications are common; the complications are, of themselves, a major reason to manage diabetes. Recent data from Australia and similar developed health care systems overseas indicate that morbidity and mortality outcomes relating to diabetes complications are improving. However, these benefits are offset by increasing numbers of people diagnosed with diabetes, resulting in an increased disease burden with significant health care implications. Thus the imperative to prevent diabetes and diabetes complications has never been greater. Furthermore, the recognised spectrum of diabetes complications is broadening, especially complications relating to lipid levels, insulin resistance and the metabolic syndrome. Clinicians now need to be aware of both traditional complications (eg, nephropathy and cardiovascular disease) and non-traditional complications (eg, polycystic ovary syndrome, non-alcoholic fatty liver disease, some cancers and eating disorders). Complications outcomes could be further improved by decreasing the evidence-treatment gap - for example, by increasing personalisation of care in managing diabetes complications.

Entities:  

Mesh:

Year:  2015        PMID: 25832152     DOI: 10.5694/mja14.01234

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

Review 1.  Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes.

Authors:  Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2018-02-06       Impact factor: 5.782

2.  The Research of Improved Grey GM (1, 1) Model to Predict the Postprandial Glucose in Type 2 Diabetes.

Authors:  Yannian Wang; Fenfen Wei; Changqing Sun; Quanzhong Li
Journal:  Biomed Res Int       Date:  2016-05-23       Impact factor: 3.411

3.  The Role of Negative Affect in the Assessment of Quality of Life among Women with Type 1 Diabetes Mellitus.

Authors:  Nicola R Gawlik; Malcolm J Bond
Journal:  Diabetes Metab J       Date:  2017-11-07       Impact factor: 5.376

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.